The transfection efficiency of wild-type p53 (wtp53) was investigated in retinoblastoma (RB) Y79 cells using an ultrasound microbubble technique. A human RB nude mouse xenograft tumour model was also used to investigate whether this technique could deliver wtp53 into solid tumours. Reverse transcription-polymerase chain reaction (RT-PCR) demonstrated that wtp53 was successfully transfected into Y79 cells in the plasmid with microbubbles and ultrasound group and in the plasmid with liposomes group, but not in the plasmid with ultrasound group or in the untreated control group. Flow cytometry showed that apoptosis was highest in the microbubbles and ultrasound group (25.58%) compared with the plasmid with liposomes group (19.50%), and the other two groups (< 10%). RT-PCR also showed that the wtp53 gene was successfully transfected into solid tumours in the plasmid with microbubbles and ultrasound group. This study provides preliminary evidence in support of a potential new approach to RB gene therapy.
Introduction
Retinoblastoma (RB) is the most common malignant intraocular tumour in children. There are about 1000 new cases annually in China, accounting for 20% of new cases worldwide. 1 After 1809, when Dr James Wardrop first developed a surgical procedure to treat RB, 2 enucleation became the standard treatment in the 19th and 20th Centuries and is still used in most areas of China. In 1921, Dr Verhoeff began external radiation therapy for RB, which became one of the two cornerstones of RB therapy for more than half a century. 1 During this period, the survival rate for RB in the USA was nearly 90%. 1 In 1993, however, it was found that about 35% of patients had other malignant tumours (secondary malignancies) after external radiation therapy for RB, which led J Luo, X Zhou, L Diao et al. Transfection of p53 using an ultrasound microbubble intensifier to a very poor prognosis. 3 This prompted several major international RB treatment centres to attempt to treat RB with systemic chemotherapy. 4 -7 Thus, the international consensus on RB treatment has changed significantly over the past decade. Currently, chemotherapy combined with active repeated local treatment has become the first-line treatment for RB, while external radiation therapy has been reduced to a second-line treatment and enucleation is a third-line treatment. These changes are considered to herald a new era in the treatment of RB, 8 and the most important goal of treatment is now to preserve the eye and sight as much as possible. 9 At present, the survival rate of children in developed countries has reached about 95%, while the eye preservation rate for early and mid-term RB is > 90%; for advanced tumours, it is close to 50%. 10 In recent years, with great developments in molecular biology and in understanding of the pathogenesis of tumours, gene therapy has become more targeted, precisely controlled and efficient, and it is gaining importance in cancer therapy. Gene therapy for RB is still at an early stage but includes studies of suicide gene therapy, 11 RB gene replacement therapy, 12 oncolytic herpes simplex virus gene therapy, 13 and antiangiogenesis gene therapy. 14 As a new gene vector, microbubbles can be broken by ultrasound to release a plasmid at a specific site, making gene transfection both efficient and targeted. 15 In the present study, the optimal parameters of microbubble ultrasound were explored by detecting the transfection efficiency of the wild-type p53 (wtp53) gene in RB (Y79) cells (in vitro experiments) and in RB tissues (in vivo xenograft experiments). The inhibition of growth of Y79 cells by the wtp53 gene was also evaluated using different gene transfection methods and a potential new approach to the treatment of RB was investigated.
Materials and methods

IN VITRO HUMAN RB CELL LINE Y79
The human RB cell line Y79 (KG-052; KeyGen Biotech Co. Ltd, Nanjing, China) was cultured in RPMI-1640 medium (Invitrogen, Carlsbad, CA, USA) supplemented with 20% fetal bovine serum (FBS) at 37°C in 5% carbon dioxide. The day before ultrasound exposure, cells were counted and seeded in six-well plates at a concentration of 2 × 10 5 cells/well. Approximately 60 -80% confluence was reached on the day of ultrasound exposure.
MICROBUBBLE PREPARATION
To prepare the microbubbles, 3 ml of physiological saline was injected into the fluorocarbon lyophilized preparation (obtained from the Department of Pharmacy, Nanfang Hospital, Southern Medical University, TongHe, GuangZhou, China) and oscillated until complete dissolution was obtained. The density of the microbubbles was 1.2 × 10 9 /ml, with a diameter of 4 -6 µm and a half-life of about 6 h. The ultrasonic gene transfection instrument (UGT1025) could launch ultrasonic frequencies of 300 kHz at an acoustic intensity of 0.25 -2.5 W/cm 2 and was developed by the Institute of Ultrasonic Imaging, The Second Affiliated Hospital of Chongqing University of Medical Sciences (Chongqing, China).
The cultured Y79 cells were divided into six groups, all given ultrasound at an acoustic intensity of 0.5, 0.75 and 1.0 W/cm 2 , three of the groups being exposed to the ultrasound for 60 s and the other three for 30 s. All six groups received microbubbles at a concentration of 10%. 16 For all six J Luo, X Zhou, L Diao et al. Transfection of p53 using an ultrasound microbubble intensifier groups, the Y79 cells were stained with 0.4% trypan blue for 4 min, and the stained and unstained cells were then counted in order to determine the effect of the microbubble ultrasound treatment on cell viability. The experiment was repeated three times.
TRANSFECTION OF HUMAN RB CELL LINE Y79 WITH PC53-SN3 PLASMID
The pC53-SN3 plasmid grown in Escherichia coli (both obtained from Kun-Xian Shu of the Institute of Biological Information, Chongqing University of Post and Telecommunications, Chongqing, China) was purified using a plasmid extraction kit (Axygen Biosciences, Union City, CA, USA) and suspended in 2.5 mM Tris-HCl (pH 8. Three eye drops (Santen Pharmaceutical Co. Ltd, Osaka, Japan) were used to achieve local anaesthesia and three eye drops of compound tropicamide (Santen Pharmaceutical Co. Ltd) were used to achieve pupil dilation. Then, 5 µl of cell suspension was withdrawn using a 10 µl trace syringe and the needle was inserted through the ciliary body of the eye under the guidance of an anatomy microscope (Topcon Corp., Tokyo, Japan). The tip was pointed toward the optic disc, the needle was then retracted to allow natural overflow of a small amount of vitreous humor and the cell suspension was subsequently injected into the vitreous cavity. The surgery was J Luo, X Zhou, L Diao et al.
IN VIVO ANIMAL EXPERIMENTS
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completed by spreading erythromycin eye ointment (Nanjing Baijingyu Pharmaceutical Co. Ltd, Nanjing, China) on the eyes. Tumour growth was observed by the naked eye and direct ophthalmoscopy every 2 days after transplantation and success was determined by examining haematoxylin and eosin (H&E) stained tumour samples.
Eight tumour-bearing mice were achieved from the aforementioned process and they were randomly divided into two groups, each with four mice and eight eyes: (i) the plasmid with microbubbles group, which was given a tail vein injection of 0.2 ml of microbubble contrast agent containing 0.1 mg plasmid; and (ii) the plasmid with microbubbles and ultrasound group, which was given a mixture of 0.2 ml of microbubble contrast agent and 0.1 mg plasmid injected into eyeballs that were exposed to ultrasonic energy of 0.5 W/cm 2 and working time of 20% (4 s ultrasonic irradiation, 24 s rest, 60 s sharing time). The mice were killed 7 days after transfection and the eyeballs were removed. The left eyes were paraffin embedded, sectioned and stained with H&E to observe their histological morphology. The right eyes were used for reverse transcription-polymerase chain reaction (RT-PCR) to show the transfection efficiency of the wtp53 gene.
IN VITRO SEMI-QUANTITATIVE RT-PCR
To suspend and decompose the cells, 10 × 10 6 cells were collected from each group and incubated with 1.0 ml of TriPure TM isolation reagent (Boehringer Mannheim, Mannheim, Germany) at room temperature for 5 min. The cells were then centrifuged (8400 g, 4°C, 5 min) and the supernatant was transferred into a new 1.5 ml centrifuge tube, to which 0.2 ml of chloroform was added. The tube was oscillated and incubated on ice for 5 min, then 0.5 ml isopropanol was added and the tube was again oscillated and incubated on ice for 5 min. The mixture was again centrifuged (8400 g, 4°C, 10 min) and the supernatant was placed into a new 1.5 ml centrifuge tube, to which 0.5 ml of isopropanol was added. The tube was then oscillated and incubated on ice for 5 min, before the mixture was again centrifuged (8400 g, 4°C, 5 min) and the supernatant was discarded. Then, 1.0 ml of 75% ethanol was added and the tubes were oscillated and then centrifuged (5300 g, 4°C, 5 min) and the supernatant discarded. The pellet was transparent at room temperature. Diethylpyrocarbonate (DEPC)-treated water 0.1% (10 -35 µl) was added to dissolve the RNA and the integrity of total RNA was identified using a spectro photometer (optical density ratio 260/280 nm) and 1.5% agarose gel electrophoresis.
The RT reaction mixture consisted of 4 µl total RNA, 18 µl oligodeoxythymidylic acid (Takara Bio Inc., Shiga, Japan) and 6 µl of DEPC-treated water. The mixture was heated to 70°C for 5 min and then placed in an ice bath before the addition of 5 µl of 5 × RT buffer, 2 µl of 10 mmol/l deoxynucleotide triphosphates (dNTPs), 2 µl of ribonuclease inhibitor (RNAsin) and 1 µl (2000 U) of Moloney murine leukaemia virus reverse transcriptase (all from Takara Bio Inc.). The mixture was incubated at room temperature for 5 min, heated to 42°C for 60 min, then to 70°C for 10 min and then immediately placed in an ice bath.
The PCR reaction mixture (50 µl) consisted of 30.75 µl double-distilled water, 5 µl reaction buffer, 3 µl Mg 2+ (Takara Bio Inc.), 4 µl dNTPs, 2 µl of upstream primer P 1 (5′-GAGAATCTCCGCAAGAAAGG-3′) and 2 µl of downstream primer P 2 (5′-GCAAGC AAGGGTTCAAAGAC-3′) (Shanghai Sangon 
The PCR products were stained with ethidium bromide (0.5 µg/ml) and detected using 2% agarose gel electrophoresis (80 V, 30 min). The mean fluorescence intensity was calculated and statistically analysed using gel documentation (Gel Doc; Gel Imaging Systems, Roche, Basel, Switzerland).
IN VIVO SEMI-QUANTITATIVE RT-PCR
To extract total RNA, 50 µg of RB tumour tissue was ground and the RNA extracted using a total cellular RNA extraction kit (BioEngineering Co. Ltd, Shanghai, Shanghai, China) and agarose gel electrophoresis was used to show the 28S and 18S rRNAs bands. The PCR was carried out in a volume of 50 µl, as for the in vitro experiment, and β-actin (540 bp; Beijing Ding States Biological Technology Co. Ltd, Beijing, China) was used as the internal control.
APOPTOSIS RATE
To test the rate of apoptosis, Y79 cells were collected by centrifugation (300 g for 5 min) and washed twice with 10 mM phosphatebuffered saline (PBS), pH 7.2. Approximately 1 -5 × 10 5 cells were collected and resuspended in 500 µl of binding buffer before adding 2 µl of Annexin V fluorescein isothiocyanate from the Apoptosis Detection Kit (KeyGen Biotech. Co. Ltd, Nanjing, China) and 5 µl of propidium iodide. The reaction was left in the dark at room temperature for 5 min. The apoptosis rate was measured by flow cytometry using a BD FACSCalibur™ flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA) (excitation 488 nm, emission 530 nm).
HISTOLOGICAL OBSERVATIONS
Eyeballs were fixed in 4% paraformaldehyde solution and then conventionally processed through paraffin embedding, dehydration, sectioning and H&E staining. The histological features of the tumours were observed using an optical microscope (CX41; Olympus, Tokyo, Japan).
STATISTICAL ANALYSIS
All analyses were carried out using the SPSS ® statistical package, version 12.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . The F-test and paired t-test were used to analyse cell viability data for trypan blue staining. The ttest was used to analyse the results of RT-PCR, and the F-test was used to analyse the rate of apoptosis. A P-value < 0.05 was considered to be statistically significant for all tests.
Results
Y79 CELL VIABILITY: IN VITRO
The in vitro survival rate of Y79 cells in each group, assessed by trypan blue staining is shown in Table 1 . When ultrasound was conducted with 300 kHz, 0.5 W/cm 2 , 30 s, continuous wave, and a microbubble concentration of 10%, cell survival was > 95%. These results showed that the response of Y79 cells was good at this acoustic intensity, acoustic exposure time and concentration of microbubble contrast agent, and that cell viability was not affected.
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RT-PCR: IN VITRO
Semi-quantitative RT-PCR was used to detect the expression of wtp53 mRNA in Y79 cells according to the mean optical density of PCR products separated by agarose gel electrophoresis. The results showed that wtp53 expression was not detected in the plasmid with ultrasound group or in the blank control group (Fig. 1) . In the plasmid with microbubbles and ultrasound group and the plasmid with liposome group, wtp53 expression was detected. The difference between the plasmid with microbubbles and ultrasound group and the plasmid with liposome group was statistically significant (P = 0.001) ( Table 2) . 
RT-PCR: IN VIVO
The RT-PCR results showed that wtp53 expression (418 bp band) was detected in the plasmid with microbubbles and ultrasound group but not in the plasmid with microbubbles group (Fig. 2) . This indicates that the wtp53 gene had been successfully transfected into the tumour tissue of a human RB nude mouse xenograft tumour model.
APOPTOSIS RATE
Flow cytometry detection of the apoptosis rate in the four Y79 groups showed that the rate in the plasmid with microbubbles and ultrasound group was 25.58% (P = 0.001 compared with the other three groups), in the plasmid with liposome group it was 19.50% (P = 0.001 compared with the other three groups), and in the other two groups it was < 10% (no statistically significant between-group differences) ( Table 3) .
ESTABLISHMENT OF A XENOGRAFT TUMOUR MODEL AND HISTOLOGICAL OBSERVATION
Among 14 attempts in BALB/c (nu/nu) nude mice, there were eight cases of successful a Expression of wtp53, expressed relative to β-actin, was detected in the plasmid plus microbubbles and ultrasound group and the plasmid plus liposome group, but not in the plasmid with ultrasound group and the blank control group (see Fig. 1 ). ***P = 0.001 for the plasmid with microbubbles and ultrasound group versus the plasmid with liposome group. (Fig. 3) . In RB tumour tissues, there was less cytoplasm than in normal tissue and the nuclei were deeply stained. Tumour cells grew around the vascular lumen and resembled a chrysanthemum under a highpower microscope (Fig. 4) .
Discussion
Retinoblastoma is the most common intraocular malignancy in childhood and, in China, it is primarily treated by eye enucleation. In the past few years, however, the treatment of tumours by promoting differentiation using gene therapy has been advocated. 17 The key to gene therapy, and its biggest obstacle, is the development of safe, efficient targets for gene transfer vectors.
The p53 gene has a very close relationship with human malignant neoplasms. 18 Mutant p53 is detected in most solid RB tumours, 19, 20 but it is not found in normal retinal tissue. When there is a mutation in the p53 gene, its monitoring capacity is lost and it becomes an oncogene. 21 The wtp53 gene has anticarcinoma effects and an inhibitory effect on angiogenesis. Thus, it has been postulated that transfecting the wtp53 gene into tumour cells might induce cell apoptosis J Luo, X Zhou, L Diao et al. Transfection of p53 using an ultrasound microbubble intensifier and several studies have been carried out to explore the therapeutic potential of this strategy against malignant neoplasms. 22 -24 Uptake of the wtp53 gene may also cause tumour cells to increase their sensitivity to radiotherapy and chemotherapy drugs, accelerating their apoptosis, 25 and reducing the side-effects of radiotherapy and chemotherapy. 26 It has been shown that wtp53 may increase tumour cell sensitivity to chemotherapeutic drugs by means of nonapoptotic regulation. 27 As a novel gene transfer vector, the microbubble contrast agent can be broken by ultrasound exposure in designated areas in order to release the gene it carries. The shock from bursting the microbubbles can increase the membrane permeability of cells, and the ultrasound energy and the shocks from the rupture of the microbubbles can promote delivery of DNA from the endocytosis foam of the cells, thereby promoting DNA entry into the nucleus. 28 These factors greatly improve the efficiency of gene transfer and expression. 29 Several reports have shown enhanced efficiency of gene transfection with this technique in liver, myocardial and ovarian cells. 30 -34 Too high a concentration of microbubbles, however, may have a negative impact on cell activity and the use of ultrasound at a certain range of sound intensity and period of time when used to break the microbubbles, can harm the cells and even cause cell death. 35 Thus, in the present study, different ultrasound intensities and different concentrations of microbubbles were used in the preliminary experiments to identify the optimal experimental conditions. Trypan blue staining showed that, when the sound intensity was 0.5 W/cm 2 , the ultrasound exposure time was 30 s and the microbubble concentration was 10%, > 95% of Y79 cells were able to survive.
Under different transfection conditions, the transfection efficiency of wtp53 varied. It was clear that the transfection efficiency in the plasmid plus microbubbles and ultrasound group was significantly higher than that of the plasmid plus liposome group, suggesting that microbubbles as a novel transfection medium could meet the need for efficient gene transfer. These conclusions were also confirmed by semiquantitative RT-PCR analysis. The Y79 cells showed wtp53 mRNA expression in both the plasmid plus liposome group and in the plasmid plus microbubble and ultrasound group. No expression was detected, however, in the control group or plasmid plus ultrasound alone groups, which suggested that the amount of plasmid transfected into Y79 cells was low, resulting in weak expression of wtp53. Alternatively, it is also possible that the wtp53 mRNA may have been quickly degraded during the course of the experimental procedures.
In the in vivo animal experiments, suitable experimental parameters for pre-screening were used: 16, 36 microbubble concentration of 10%, ultrasound intensity of 0.5 W/cm 2 and an exposure time of 30 s. The results of semiquantitative RT-PCR showed that the ultrasound plus microbubble technique could facilitate the transfection of wtp53. In addition, by using intravenous transmission, the target gene could be transfected efficiently, easily and non-invasively.
In summary, the present study explored the efficiency of wtp53 plasmid transfection into Y79 cells and RB xenograft tumour tissues mediated by an ultrasound plus microbubble technique. This is a preliminary study of RB gene therapy mediated by ultrasound and microbubbles and provides evidence in support of a potential new approach to RB gene therapy.
